Andrew James Brown

Title: Andrew James Brown: Innovator in G Protein Research

Introduction

Andrew James Brown is a notable inventor based in Hitchin, GB. He has made significant contributions to the field of biochemistry, particularly in the development of chimeric G proteins. His work has implications for drug discovery and receptor interaction studies.

Latest Patents

Andrew holds a patent for "G protein chimeras and methods of screening compounds." This patent describes a chimeric G protein that incorporates modified yeast G (Gpa1p) amino acid sequences. The modifications involve substitutions at a minimum of three amino acid positions within the C-terminal 10 amino acids. The patent also details a transformed yeast cell that contains this chimeric G protein and outlines a method for screening compounds that can interact with a receptor. This method involves contacting a compound of interest with the yeast cell and observing either the growth response of the cell or the production of a reporter gene product. Andrew has 1 patent to his name.

Career Highlights

Andrew is currently employed at Glaxo Wellcome Inc., where he continues to advance his research in biochemistry and pharmacology. His work at the company has allowed him to collaborate with other experts in the field, enhancing the impact of his innovations.

Collaborations

One of Andrew's notable coworkers is Simon Jeremy Dowell. Their collaboration has contributed to the development of innovative solutions in their research area.

Conclusion

Andrew James Brown is a distinguished inventor whose work on G protein chimeras has the potential to influence drug discovery and receptor interaction methodologies. His contributions to the field are noteworthy and continue to inspire further research and innovation.